Grzegorz Satała

2.7k total citations
125 papers, 2.0k citations indexed

About

Grzegorz Satała is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Grzegorz Satała has authored 125 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 83 papers in Molecular Biology, 73 papers in Organic Chemistry and 42 papers in Cellular and Molecular Neuroscience. Recurrent topics in Grzegorz Satała's work include Receptor Mechanisms and Signaling (45 papers), Synthesis and Biological Evaluation (39 papers) and Neurotransmitter Receptor Influence on Behavior (25 papers). Grzegorz Satała is often cited by papers focused on Receptor Mechanisms and Signaling (45 papers), Synthesis and Biological Evaluation (39 papers) and Neurotransmitter Receptor Influence on Behavior (25 papers). Grzegorz Satała collaborates with scholars based in Poland, France and Germany. Grzegorz Satała's co-authors include Andrzej J. Bojarski, Paweł Zajdel, Anna Wesołowska, Anna Partyka, Rafał Kurczab, Magdalena Jastrzębska‐Więsek, Maciej Pawłowski, Agata Siwek, Vittorio Canale and Beata Duszyńska and has published in prestigious journals such as Nature Communications, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Grzegorz Satała

123 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Grzegorz Satała Poland 26 1.0k 829 515 330 321 125 2.0k
Paweł Zajdel Poland 23 856 0.8× 693 0.8× 396 0.8× 260 0.8× 182 0.6× 94 1.6k
Agnieszka A. Kaczor Poland 24 1.1k 1.1× 418 0.5× 644 1.3× 219 0.7× 299 0.9× 131 2.0k
Maciej Pawłowski Poland 28 1.3k 1.3× 953 1.1× 491 1.0× 406 1.2× 307 1.0× 152 2.5k
Magdalena Jastrzębska‐Więsek Poland 23 668 0.6× 448 0.5× 439 0.9× 285 0.9× 148 0.5× 80 1.3k
Thomas Balle Denmark 26 1.3k 1.3× 416 0.5× 417 0.8× 294 0.9× 345 1.1× 91 2.0k
Gabriella Marucci Italy 27 1.4k 1.4× 828 1.0× 488 0.9× 582 1.8× 320 1.0× 147 2.7k
Agostino Marrazzo Italy 31 1.7k 1.7× 459 0.6× 617 1.2× 304 0.9× 203 0.6× 126 2.4k
Albert J. Robichaud United States 29 1.1k 1.0× 1.1k 1.4× 742 1.4× 570 1.7× 336 1.0× 74 2.8k
Anna L. Blobaum United States 29 1.2k 1.2× 691 0.8× 888 1.7× 579 1.8× 172 0.5× 97 2.6k
Ki Duk Park South Korea 30 1.1k 1.1× 695 0.8× 581 1.1× 419 1.3× 127 0.4× 116 2.7k

Countries citing papers authored by Grzegorz Satała

Since Specialization
Citations

This map shows the geographic impact of Grzegorz Satała's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Grzegorz Satała with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Grzegorz Satała more than expected).

Fields of papers citing papers by Grzegorz Satała

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Grzegorz Satała. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Grzegorz Satała. The network helps show where Grzegorz Satała may publish in the future.

Co-authorship network of co-authors of Grzegorz Satała

This figure shows the co-authorship network connecting the top 25 collaborators of Grzegorz Satała. A scholar is included among the top collaborators of Grzegorz Satała based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Grzegorz Satała. Grzegorz Satała is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jaśkowska, Jolanta, Grzegorz Satała, Paula Zaręba, et al.. (2025). Discovery of new dual butyrylcholinesterase (BuChE) inhibitors and 5-HT7 receptor antagonists as compounds used to treat Alzheimer’s disease symptoms. Biomedicine & Pharmacotherapy. 186. 117995–117995. 3 indexed citations
2.
Łażewska, Dorota, Małgorzata Więcek, Grzegorz Satała, et al.. (2023). New Triazine Derivatives as Serotonin 5-HT6 Receptor Ligands. Molecules. 28(3). 1108–1108. 3 indexed citations
3.
Załuski, Michał, Tadeusz Karcz, Anna Drabczyńska, et al.. (2023). Xanthine–Dopamine Hybrid Molecules as Multitarget Drugs with Potential for the Treatment of Neurodegenerative Diseases. Biomolecules. 13(7). 1079–1079. 7 indexed citations
4.
Brandt, T, Vladimir Shalgunov, Celia Kjærby, et al.. (2023). Repeated low doses of psilocybin increase resilience to stress, lower compulsive actions, and strengthen cortical connections to the paraventricular thalamic nucleus in rats. Molecular Psychiatry. 28(9). 3829–3841. 23 indexed citations
5.
Canale, Vittorio, Séverine Chaumont‐Dubel, Paulina Koczurkiewicz, et al.. (2022). 1-(Arylsulfonyl-isoindol-2-yl)piperazines as 5-HT6R Antagonists: Mechanochemical Synthesis, In Vitro Pharmacological Properties and Glioprotective Activity. Biomolecules. 13(1). 12–12. 11 indexed citations
6.
Zajdel, Paweł, Katarzyna Grychowska, Szczepan Mogilski, et al.. (2021). Structure-Based Design and Optimization of FPPQ, a Dual-Acting 5-HT3 and 5-HT6 Receptor Antagonist with Antipsychotic and Procognitive Properties. Journal of Medicinal Chemistry. 64(18). 13279–13298. 11 indexed citations
8.
Staroń, Jakub, Ryszard Bugno, Rafał Kurczab, et al.. (2021). Tuning the activity of known drugs via the introduction of halogen atoms, a case study of SERT ligands – Fluoxetine and fluvoxamine. European Journal of Medicinal Chemistry. 220. 113533–113533. 20 indexed citations
9.
Canale, Vittorio, Séverine Chaumont‐Dubel, Rafał Kurczab, et al.. (2021). Imidazopyridine-Based 5-HT6 Receptor Neutral Antagonists: Impact of N1-Benzyl and N1-Phenylsulfonyl Fragments on Different Receptor Conformational States. Journal of Medicinal Chemistry. 64(2). 1180–1196. 15 indexed citations
10.
Hogendorf, Adam S., Rafał Kurczab, Grzegorz Satała, et al.. (2021). N-Skatyltryptamines—Dual 5-HT6R/D2R Ligands with Antipsychotic and Procognitive Potential. Molecules. 26(15). 4605–4605. 4 indexed citations
11.
Staroń, Jakub, Ryszard Bugno, Grzegorz Satała, et al.. (2020). Rationally designed N-phenylsulfonylindoles as a tool for the analysis of the non-basic 5-HT6R ligands binding mode. European Journal of Medicinal Chemistry. 209. 112916–112916. 3 indexed citations
12.
Herold, Franciszek, Maciej Dawidowski, Agata Siwek, et al.. (2019). Synthesis and biological evaluation of new multi-target 3-(1H-indol-3-yl)pyrrolidine-2,5-dione derivatives with potential antidepressant effect. European Journal of Medicinal Chemistry. 183. 111736–111736. 27 indexed citations
13.
Latacz, Gniewomir, Annamaria Lubelska, Magdalena Jastrzębska‐Więsek, et al.. (2019). The 1,3,5-Triazine Derivatives as Innovative Chemical Family of 5-HT6 Serotonin Receptor Agents with Therapeutic Perspectives for Cognitive Impairment. International Journal of Molecular Sciences. 20(14). 3420–3420. 41 indexed citations
14.
Grychowska, Katarzyna, Rafał Kurczab, Paweł Śliwa, et al.. (2018). Pyrroloquinoline scaffold-based 5-HT6R ligands: Synthesis, quantum chemical and molecular dynamic studies, and influence of nitrogen atom position in the scaffold on affinity. Bioorganic & Medicinal Chemistry. 26(12). 3588–3595. 13 indexed citations
15.
Satała, Grzegorz, Beata Duszyńska, Tomasz Lenda, Gabriel Nowak, & Andrzej J. Bojarski. (2017). Allosteric Inhibition of Serotonin 5-HT7 Receptors by Zinc Ions. Molecular Neurobiology. 55(4). 2897–2910. 20 indexed citations
16.
Partyka, Anna, Rafał Kurczab, Vittorio Canale, et al.. (2017). The impact of the halogen bonding on D2 and 5-HT1A/5-HT7 receptor activity of azinesulfonamides of 4-[(2-ethyl)piperidinyl-1-yl]phenylpiperazines with antipsychotic and antidepressant properties. Bioorganic & Medicinal Chemistry. 25(14). 3638–3648. 25 indexed citations
17.
Kucwaj‐Brysz, Katarzyna, Dawid Warszycki, Sabina Podlewska, et al.. (2016). Rational design in search for 5-phenylhydantoin selective 5-HT7R antagonists. Molecular modeling, synthesis and biological evaluation. European Journal of Medicinal Chemistry. 112. 258–269. 17 indexed citations
18.
Żmudzki, Paweł, Grzegorz Satała, Grażyna Chłoń‐Rzepa, et al.. (2015). N -(4-Arylpiperazinoalkyl)acetamide derivatives of 1,3- and 3,7-dimethyl-1 H -purine-2,6(3 H ,7 H )-diones and their 5-HT 6 , 5-HT 7 , and D 2 receptors affinity. Heterocyclic Communications. 21(1). 13–18. 5 indexed citations
19.
Canale, Vittorio, Rafał Kurczab, Anna Partyka, et al.. (2014). Towards novel 5-HT7 versus 5-HT1A receptor ligands among LCAPs with cyclic amino acid amide fragments: Design, synthesis, and antidepressant properties. Part II. European Journal of Medicinal Chemistry. 92. 202–211. 18 indexed citations
20.
Obniska, Jolanta, et al.. (2012). Synthesis, anticonvulsant activity and 5-HT1A/5-HT7 receptors affinity of 1-[(4-arylpiperazin-1-yl)-propyl]-succinimides. Pharmacological Reports. 64(2). 326–335. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026